23 February 2017 Final Results from NICHE Phase III trial presented at the International Stroke Conference
(WorldNews Finland)

23 February 2017 Nexstim Plc (NXTMH:HEX, NXTMS:STO) (`Nexstim` or `Company`), a medical technology company with a pioneering navigated non-invasive brain stimulation system, today presented the final results of a multi-center Phase III trial in stroke rehabilitation (NICHE trial) assessing the Company`s Navigated Brain Therapy system (NBT®) at the International Stroke Conference in Houston, TX. The presentation, by the trial Principal Investigator, Richard L. Harvey, MD, Rehabilitation Institute of Chicago, summarised the main safety and efficacy results of the NICHE trial, previously announced in March 2016. The safety results were good with no serious adverse events (SAE)...